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Type I trans glutaminase (TGase I, keratinocyte or particulate 
transglutaminase) is a 92-kilodalton (kDa) prot:ein expressed 
in abundance in cultured keratinocytes and in t:he hyperpro-
liferative skin disorder psoriasis. To determine t:he e,cpression 
ofTGase I protein and mRNA, we studied tissue a.nd estab-
lished squamous carcinoma lines derived from different 
sources. Immunohistochemistry and Western blotting were 
used to detect TGase I protein with the B.Cl mouse mono-
clonal antibody. Only well-differentiated, skin-derived 
squamous carcinomas stained for TGase 1. However, a pre-
cocious pattern of expression was seen overlying less-differ-
entiated tumors. Compared to cultured human keratinocytes, 
squamous cell carcinoma (SCC) had many times less to 7.8 
times more TGase I protein, greatest in the two most differ-
Keratinocytes undergoing terminal differentiation form a cornified barrier, the stratum corneum, which is critical for host survival. Skin cancers derived from keratinocytes are the most common of all human cancers, and include basal cell carcinomas (Bees) and 
squamous cell carcinomas (Sees) . Squamous cell carcinomas, espe-
cially those derived from mucosal surfaces, are more aggressive, 
metastasize more frequently, and are associated with greater mor-
bidity and mortality than Bees. 
Transglutaminase enzymes catalyze the cross-lioking of proteins 
through formation of e-(y-glutamyl) lysine isopeptide bonds that 
help to form the cornified layer [1]. A number of proteios expressed 
in terminal differentiation are substrates for transgluta.minase, in-
cluding loricrin, involucrin, keratohyalin, and a 130-kDa protein 
[2,3]. The skin contains three distinct transglutaminases: TGase I 
(keratinocyte or particulate transglutaminase [4,5], TGase III (epi-
dermal trans glutaminase [6,7]), and TGase II (tiss~e transglutamin-
ase [8,9]). TGase I, first isolated as a 92-kDa melYlbrane-associated 
membrane, is recognized by the monoclonal antibody B.el [4,5]. 
Manuscript received August 19, 1993; accepted for publication December 
2, 1993. 
This work was presented in part at the Gordon Conference on Epidermal 
Differentiation, Aug 2-6, 1993, Tilton, NH. 
Reprint requests to: Dr. Madeleine Duvic, Department of Dermatology, 
University of Texas Medical School, 6431 Fannin, 1.184, liouston, Texas 
77030. 
Abbreviations: BCE, basal cell epithelioma; HUK. humiii" epidermal 
foreskin keratinocytes; KTG, keratinocyte transglutarninase; RT-PCR, re-
verse transcriptase-polymerase chain reaction; TGase, trans glutaminase. 
entiated tumor lines 14-83 and ME-180. TGase I mRNA 
levels ranged from 0.010 to 0.00004 pg/,ug total RNA by 
reverse transcriptase-polymerase chain reaction using an in-
ternal standard. Protein expression correlated with mRNA 
levels in most SCC lines. When a human TGase I promoter 
was isolated and used to study genomic DNA, SCC 1-83 was 
shown to have unique restriction enzyme fragments, includ-
ing one indicative of methylation differences, also present 
within DNA from the KB line. These studies suggest that 
transcriptional control of TGase I gene expression in squa-
mous carcinomas may be influenced both by cis elements in 
the promoter and by the degree of tumor squamous differen-
tiation. Key words: epidermal differentiation/epidermis/skitl 
cancer /cornijled envelope. ] Invest Dermatol1 02:462 -469, 1994 
TGase I is highly expressed in cultured keratinocytes, is downregu-
lated by administration of retinoic acid, and is induced by TPA, 
calcium, and cell confluency ;"1 vitro [10-13] . 
Psoriasis and squamous cell carcinomas have in common epider-
mal hyperproliferation and response to retinoids [14]. Psoriasis is an 
inherited, self-limited reversible state of local epidermal hyper-
proliferation without progression to malignancy, which may be 
initiated by inflammation [15]. Precocious expression of TGase I 
and involucrin has been noted in psoriatic lesions [5,16]. There 
is a sixfold or greater increase in TGase I mRNA expression, 
which might explain the hyperkeratosis characteristic of psoriatic 
lesions [17] . 
Squamous cell carcinomas arise on any epithelial surface and vary 
in degree of squamous differentiation. TGase I has been suggested 
to be a marker for the state of differentiation in lung cancers [18] and 
in rabbit trachea [19] . In epidermal dysplasia of the oral cavity it has 
been shown to be uncoupled with involucrin expression [20]. TGase 
I activity and expression in response to retinoic acid varies among 
various squamous cell carcinoma lines but the mechanisms are un-
known [20 - 26]. We determined the level of expression ofTGase I 
protein and mRNA in squamous cell carcinomas and observed vari-
ation that correlated with the degree of squamous differentiation. 
MATERIALS AND METHODS 
Immunoperoxidase Detection Seven squamous cell carcinomas, 14 
basal cell carcinomas, and 15 normal skin biopsies were embedded and 
snap-frozen in Tissue-Tek OCT (Mile, Naperville, IN). The SCC tumors, 
examined by routine histology, included one SCC in situ, one keratoacanth-
oma (considered by some to be a well-differentiated scq, two well-differ-
entiated SCCs, and three poorly differentiated secs. Four-micron sections 
placed on Poly-L-Iysine (Sigma, St. Louis, MO}-coated slides were fixed in 
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cold acetone and incubated overnight with RC1 at 1 : 4 dilution [4]. TGase I 
detection was done with goat anti-mouse biotinylated immunoglobulin G 
(IgG) and strept~vidi~-biotin im~l~noperoxidase (LS~ kit, DAKO, Car-
pinteria, CAl With dlamll1obenzldll1e tetrahydrochlonde (DAB; DAKO) 
chromogen, counterstained with 1 % Mayer's hematoxylin. Pre-immune 
m ouse sera were used as a control. The slides were examined by light micros-
copy and photographed. 
Normal and Squamous Cell Lines Keratinocytes and fibroblasts were 
explanted from discarded neonatal foreskin as previously described [27]. 
Well-characterized squamous carcinomas included 14-83, a very well dif-
fere ntiated SCC derived from the retromolar trigone area, and 1-83, a poorly 
differentiated aggressive SCC derived from tonsil [28,29]' The two lines 
were established at the M.D. Anderson Cancer Center. SRll-1 was a moder-
ately differentiated, deeply invasive SCC arising on sun-exposed scalp, 
which quickly reoccurred, causing fatal intracranial metastases. SRll-12 was 
a nodal metastasis from a well-differentiated, deeply invasive squamous cell 
carcinoma of skin of the neck. The KB line (an undifferentiated SCC derived 
from the floor of the mouth), the A431 line (cervical SCC) (30), and the 
ME-180 line (vulvar SCC) were purchased from the ATCC, Rockville, 
Maryland (31) . AII ·lines were found to be free from mycoplasma contamina-
tion (Genzyme, Pierce). 
Cell Culture Human foreskin keratinocytes were cultured by the modi-
fied method of Kitano and Okada as described (27) in keratinocyte growth 
medium (KGM) serum-free media, 0.15 mM calcium (Clonetics, CAl. Ex-
planted human foreskin fibroblasts were grown in Dulbecco's modified 
Eagle's medium (DMEM; Gibco) with 10% fetal bovine serum (FBS) (32). 
The following media supplemented with 10% FBS and 1 % fungibact 
(Gibco-BRL) were used to grow SCC lines: DMEM (A431 , 1-83), mini-
m um essential medium (MEM) (KB and 14-83), and DMEM/HAM12 
(SRB-l and SRll-12). A431 , 14-83, and 183 cells at densities ranging from 
3 X lOS to 3 X 106 cell/well were also plated onto chamber well slides 
(Nunc) in DMEM and Ham's F-12 3: 1 (FAD) or DMEM media and stained 
for immunoreactivity. 
Skin Equivalent System Cultured fibroblasts (2 X lOS cell s) were mixed 
with 3.5 mg/ml type I co llagen (Collaborative Biochemical Products, Bed-
ford, MA) neutralized with 1 N NaOH, and plated in 24-well plates (Cos-
tar) at 24 h with keratinocytes or A431 cells (5 X lOS cells per well) . 
Twenty-four hours later gels were raised to the air-liquid interface [33]. 
FAD medium supplemented with 10% FBS, 400 ng/ml hydrocortisone, 
10- 10 M cholera toxin (Sigma), 10 ng/ml epidermal growth factor, 1% 
fungibact, 0.089 mM adenine, 0.105 iu/ ml insulin was added to feed cells 
fro m below, 3 times per. week. TI~e rafts ,,:,ere harvested on day 21 and 
sectioned and stall1ed for nllmunolllStochemlstry. 
Western Blotting Proteins were extracted as described previously [34] 
and concentration was determined by the DC Protein Assay (Biorad, Her-
cules, CAl. Five micrograms/lane of protein were electrophoresed over a 
10% polyacrylamide gel for 1 h at 200 volts, and e1ectroblotted onto Hy-
bond membranes (Amersham, UK) (35). Human TGase I was detected using 
B.Cl at 1 : 100 dilution [5] with mouse monoclonal IgM and IgG (Sigma) as 
controls. Antibodies were detected using goat-anti-mouse IgG or IgM with 
ECL-Western chemiluminescence detection on Hyperfilm exposed for 15 
or 60 seconds (Amersham) [36]. The 92-kDa TGase I signals were analyzed 
fro m the autoradiographs by photoimage densitometry (UVP, Inc). Experi-
ments were performed twice. 
Isolation of Total RNA Total RNA was extracted from cultured cells by 
lys is with RNAzol B (Cinna/Biotecx Laboratories, Houston, TX) and pre-
cipitated as described previously [37]. The total RNA concentrations in the 
supernatants were determined by ultraviolet (UV) spectroscopy at 260 nm. 
Quantitation of mRNA by Northern Blotting Equal amounts of 
RNA (7 lig/ lane) electrophoresed on 1.2% formaldehyde agarose gels (38) 
were transferred to nylon membranes as described [37). RNA was cross-
linked by a 30-second exposure to 254 nm light with a UV-transilluminator 
(UVP, Inc), detected by UV shadowing [17,39), and photographed with 
Polaroid 55 film and a Wratten 23 filter. Prehybridization and hybridization 
were carried out with radioactive oligo-labeled 0.66-kilobase pair (kb) 3' 
EeoRl cDNA insert for human TGase I as described previously (17]. Blots 
were washed twice at room temperature for 30 minutes each with 2 X SSC/ 
0.1 % sodium dodecylsulfate (SDS) and 0.1 X SSC/ O.l % SDS, and then at 
60·C in 0.1 X SSC/O.l% SDS. Blots were autoradiographed against Kodak 
X-AR film for 14-21 d. These experiments were performed four times. 
Quantitation of Specific RNA by Reverse Transcriptase-Polymerase 
Chain Reaction (RT-PCR) To develop a more sensitive quantitative 
assay for TGase I mRNA, an internal standard for TGase I PCR was con-
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structed by inse rt ing an additional 76-base p~ir (bp) DNA Rsal lambda phage 
fragment into the eDNA [17] to give KTGO. The mutant plasmid was then 
digested with BeoR1 to release a 736-bp fragment used as a competitive 
template. cDNA was synthesized in a reaction containing 2lig of tota'! 
RNA,S mM deox,),nucleotide triphosphates (dNTPs), 2.5 liM random hex-
amers, 1 unit RNase inhibitor, and 2.5 units ofMoMuLV reverse transcrip-
tase and 1 X PCR buffer II (RNA-PCR kit, Perkins-Elmer-Cetus, Norwalk, 
CT). One-eighth of the reaction was then coamplified with defined 
amounts (0.005 - 0.0005 pg) of competitive template in a 25-JlI PCR con-
taining 0.1 liM each specific primer, 1 X PCR buffer II, 0.5 urilts Amplitaq 
DNA polymel:"ase, 2 mM MgCI2 , and no additional dNTPs, concentra-
tion <200,liM [40]. Amplification primers for human TGase I partia.! 3' 
cDNA were KTG82 5'-AAGGAGACCAAGAAGG-3' and KTG81 5'-
CTGTAACCCAGAGCCTTC 3'. Following an initial denaturizatioll at 
94 0 C for 1 min, samples were cycled through denaturing at 94 0 C X 30 
seconds, annealing at 56" C X 30 seconds, and extension at 72 0 C for 30 
seconds for 35 cycles. 
The RT-PCR pwducts of endogenous RNA (310 bp) and competitor 
standard (386 bp) were visualized by UV on 4% Nuseive agarose gels and 
photographed. Absolute areas of the peak intensities were measured by den-
sitometry on a Uvp, Inc. photodocumentation system. The ratios of the 
co~petitor band to the endog~nous band for each reaction were plotted 
agall1st the amount of competitor template added for each reaction, and 
linear regressions were calculated. The specific amount of endogenous 
TGase I mRNA (expressed in picograms/250 lig total RNA used for RT-
PCR) was determined from the point at which the ratio of the intensities 
equalled 1.0 and was multiplied by 4 to express the data per lig of total RNA. 
Southern Blotting of the TGase I Gene To study the structure of the 
TGase I gene promoter in SCCs, a human genomic TGase I clone was 
isolated from a hUloan liver genomic library in Lambda Fix using the 1.5-kb 
BcoRl cDNA insert [17]. One phage contained a 15-kb insert from which a 
2.3-kb HilldIII fragment was 100% identical to a published TGase I pro-
moter beginning at position - 382 of previously published promoter se-
quences and ext:ending 5' [41]. 
Genomic DNAs (10 lig) extracted from cultured SCC lines (Stratagene 
kit) [42] were diges ted by 5 units/lig each ofEcoRI, Hilldnr,Mspl , HpaU, and 
Pst! (Promega). The DNA fragments were separated by 0.8% or 1.2% agar-
ose gel electrophoresis in TEA buffer with lambda HilldlII and Phi X174 
fragments as standards (BRL). Zetabind membranes with transferred DNA 
were hybridized to 32P_CTP (Amersham)-labeled 2.3-kb HilldlII genomic 
TGase I fragme nt [43), washed, and autoradiographed to detect genomic 
DNA fragments, as described previously [44]. Blots were stripped (45) and 
rehybridized with the 1.5-kb partial cDNA [17]. 
RESULTS 
Skin-derived bas;).i cell epitheliomas and invasive squamous carcino-
m as lack TGase r but induce its expression in overlying normal 
epidermis. 
TGase I expression in patient skin tumors was studied in see and 
Bee tumors and adjacent normal skin using immunohistochemis-
try. Although basal cell carcinomas did not stain for TGase I (Fig 
lA), the epidermis overlying these tumors had reactivity extending 
i~to t~e basal layer in the absence of overlying epidermal hyperpla-
Sia (FIg lB) . Abnormal keratinocytes in invasive, less-differentiated 
sees did not stain (Fig lC,D) . However, the hyperproliferative 
epidermis directly overlying less-differentiated see tumors ex-
pressed TGase I ill a pattern analogous to that observed previously 
for involucril1 [46,47]. The pattern was normal in the adj acent epi-
dermis and hair follicles (Fig Ie). T wo wel l-differentiated secs 
had detectable TGase I present in the horn cyst (Fig IE) without 
induction in over! y ing epidermis. This suggests that whereas TGase 
I expression may b e lost or absent in sees in ViIlO, factors secreted by 
the tumor may induce enzym e expression in normal, overlying 
epidermis. 
Variable TGase I Protein Expression in sec Lines Detected 
by Immunochemistry TGase I was prominent as a 92-kDa band 
in cultured hUm;).u foreskin keratinocytes (Fig 2, lane 2; Table I). 
The signal intensity was 1.7 normalized against a control band. The 
ME-ISO line, which is well differentiated and derived from a vulvar 
carcinoma (Fig 2, lane 4), had a band 7.8 times more intense than 
cultured foreskin keratinocytes, whereas the 14-83 see signal was 
2.8 times greater (Fig 2, fall e 6). The see lines were grown in high 
calcium, which is known to induce TGase I, whereas the epidermal 
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Figure 2. Western bl?t analysis ofTGase I protein in normal and squamous 
cell carcinoma lmes. Five micrograms protem/lane were electrophoresed on 
10% SDS-PAGE, electroblotted, and detected with RC1 MoAb and chemi-
luminescence (ECLS, Amersham), IS-second exposure. TGase I appears as a 
92-kDa band. Lalle 1, BRL low-molecular-weight markers: 106, SO, 49.5, 
32.5,27.5, and lS.5 kDa; latle 2, cultured human foreskin keratinocytes; [aile 
3 adult human fibroblasts from breast reduction; lalle 4, ME-ISO vulvar 
squamous carcinoma line; latle 5, 1-S3 tonsil SCC line; lane 6, 14-S3 trigone 
sec line; lalle 7, SRB-1 SCC lme from scalp; latre 8, SRB-12 SCC lme from 
back; lalle 9, KB SCC line from floor of mouth; and lalle 10, A431 SCC line 
from genital tract. 
keratinocytes were grown in low calcium. Faint 92-kDa bands, 
several times less intense than in keratinocytes, were seen in the 
SRB-12 andA431 lanes. TGaseI was not detected in the 1-83 or KB 
lanes or, as expected, in control adult fibroblasts. No signal was 
detected using secondary IgG antibody alone (not shown). 
We studied several SCC lines plated at various densities and at 
different levels of confluency on chamber slides. The 14-83 line 
[28] is well differentiated and forms multilayer spheroids that stain 
heavily for TGase I (not shown). In contrast, 1-83 cells were nega-
tive by immunohistochemistry at all plating densities. However, 
A431 cell expression could be detected in a few cells and was greatly 
increased at confluency (not shown). 
To determine the pattern of expression in A431 cells, we used a 
skin equivalent system. TGase I staining in normal keratinocytes 
from foreskins (Fig IF) resembled the pattern seen in psoriasis [16] 
and overlying SCCs and BCCs. A431 cells, plated on the same 
dermal equivalent, were mostly negative (Fig IG), with the excep-
tion of a few cells found along the epidermal-dermal interface (Fig 
IH) and rare single cells in the upper layers of the raft (Fig IG, 
arrow). TGase I did not appear to be readily inducible in A431 cells. 
Expression ofTGase I mRNA by Northern Blotting North-
ern blotting (Fig 3A) was performed in parallel with Western blot-
ting in SCCs and control lines and loads were assessed by UV shad-
owing (Fig 3B). The signal for most of the mRNA bands was too 
faint for betagen scope analysis [48], and therefore could not be 
quantitated directly. Human foreskin keratinocyte mRNA levels 
were similar to the two SCC lines 14-83 and ME-180. However, 
the ME180 level of expression was probably higher, considering 
that the 28S band was less detectable than the other cell lines. A faint 
mRNA signal was detectable in SRB 12 (Fig 3, Lanf 3), which had a 
faint protein band. The KB and A431 lines (Fig 3, Lanes 1, 2), which 
did not appear to have protein by Western blotting, had almost no 
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mRNA TGase I signal. However, SRBl had an mRNA signal with 
almost no protein signal. Fibroblasts and the 1-83 metastatic SCC 
line appeared to have neither detectable TGase I mRNA nor protein 
(Table I). Although the correlation between protein and mRNA 
expression in most cell lines studied suggests that mRNA transcrip-
tion may be important in regulating TGase I in squamous carcino-
mas, other mechanisms may also be operating because some discrep-
ancies appear to exist. 
Quantitative RT-PCR Determination of TGase I mRNA 
RT-PCR was a more sensitive method for the detection of mRNA 
in SCC lines. An mRNA signal of expected size amplified by RT-
PCR was present in all SCC lines. Only dermal adult and neonatal 
fibroblasts had no mRNA detectable (Table I). Exact equivalency 
curves plotted from serial titration of competitors were established 
for cDNAs from keratinocytes and three selected SCC lines. Agar-
ose gels of competitive RT-PCR reactions are shown in Fig 4. The 
equivalency points of endogenous mRNA versus known standard in 
pg/l1g total RNA are shown in Table L The endogenous mRNA, a 
386-bp product (Fig 4, right, small top arrow), was compared to 
known amounts of competitor 31O-bp product (Fig 4, right, bottom 
ar~ow), an~plified with the same PCR primer set. As expected, fore-
skm keratmocytes, ME-180, and 14-83 cells had greatest expression 
of the mRNA, in agreement with the Western and Northern blot-
ting data. The rnRNA levels of keratinocytes (Fig 4A), ME-180 
cells (not shown), and SCC 14-83 (Fig 4C) were about equal. A431 
mRNA (Fig 4D) and 1-83 mRNA levels (Fig 4B) were 23 and 37 
times less than keratinocytes, respectively. The 1-83 RT-PCR reac-
tion also generated two bands (Fig 4B, open arrow) that were smaller 
than the expected endogenous signal of 31 0 bp. These could result 
from cDNAs for mutant TGase I alleles or differential splicing, 
PCR artifacts, or amplification of other genes or random cDNAs. 
Alterations in the TGase I Gene are Detected by Southern 
Blotting in the KB and 1-83 SCC Lines Transcription of 
mRNA may be controlled at many different levels. Cis factors are 
DNA sequences in the promoters whereas trans-regulatory factors 
may inclu~e proteins or nucleic acids that bind to specific DNA 
sequences m the promoter. Therefore, we isolated 5' genomic se-
quences within a 2.3 HindIII fragment from human TGase I to 
study the structure of genomic DNA from SCC lines. TGase I 
promot~r and gene fragments were detected by Southern blotting, 
suggestmg that all SCCs studied retain all or most of the TGase I 
gene (Fig 5). DN~ from the 1-83 line gave unique restriction en-
zyme fragments With several enzymes within the promoter (Fig 5A) 
and the gene (Fig 5B). Within the promoter, the 1-83 DNA (Fig 5, 
la~/e 1) had.a 3 .. 0-kb HindIII band and the L5-kb MspI band seen 
famtly also 111 Fig 5, lanes 15 and 18 could not be digested. Analysis 
of genomic DNA samples from leukocytes of 30 normal controls 
did not show these unique restriction fragments to be present (not 
shown). These d:J.ta suggest rearrangements, deletions, or insertions 
have occurred within the gene and promoter sequences on at least 
one allele. 
Eukaryotic gene expression may be inhibited by methylation of 
promoter cytosine bases [49]. Therefore, we compared parallel di-
gesti~n.s with methylation-sensitive (HpaU) and -insensitive (MspI) 
restriction enzyrnes to detect methylation at 5'-GGCC-3' sites 
within the TGase I promoter (Fig 5A). If the DNA were unmethy-
lated, Hpall and MspI would be expected to produce identical frag-
ments. Two identical 650- and 500-bp fragments were seen with 
Figure 1. Staining forTGase J with B.C1 using a streptavidin-biotill immunoperoxidase DAB method (DAKO) in tumors and in cultured cells in the skin raft 
equivalent. A) Basal cell carcinoma (solid arrow) is negative for TGase I but adjacent skin stains 1l0cmaHy (ope" arrow) . B) Epidermis overlying the BCE is 
compressed and suprabasallayers stain with TGase I (arrow). C,D) Moderately well-differentiated squamous carcinoma shows little staining. Epidermal 
hyperplasia with precocious expression ofTGase I is present in the normal overlying epidermis (solid arrol/l). The pattern of staining is normal in adjacent 
epidermis (open arrow) . E) Well-differentiated squamous cell carcinoma with numerous keratinized horn pearls (bottom, arrows) staining positively for TGase L 
The epidermis is not hyperplastic and shows normal staining pattern. F) Normal human foreskin keratillocytes plated on adult human fibroblasts show 
membrane expression ofTGase J in several layers of stratified epidermis, raft skin equivalent. G,H) Human A431 carcinoma cells plated on adult fibroblasts. A 
few cells at the epidermal-dermal border (H) and in the upper layers (G) stain for TGase J (arrows)' Scale bar, 50 Ii (A , B, C, D, G) and 51-1 (F, H). 
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Table I. Expression of Transglutarninase I In SCC Lines 
RT-PCR' 
Western Northern pg mRNA/ 
Line Blot Blot total RNA 
Normal cells 
HUK-confluent 
Fibroblasts 
Neonatal 
Adult 
SSC lines 
Vulvar-ME-180 
Tonsil-1-83 
Retromolar-14-83 
SRB-l 
SRB-12 
KB 
A431 
++ 
++++ 
+++ 
+/-
+/-
+/-
+++ 
+++ 
+++ 
++ 
+ 
+/-
+/-
0.0086 
0.011 
0.00002 
0.006 
+ 
+ 
+ 
0.00004 
• RT -PCR was done with an endogenous competitor and 1 : 1 eqllivalcncy was calcu-
lated by linear regression where Y = (slope) X + intercept. Y is the ratio of band 
intensities (competitor/endogenous) and X = pg added competitorj250 ng total RNA. 
The value of X for Y = 1 (equal amounts of competitor and elldogeno\ls RNA) is then 
multiplied by 4 to give pg/Ilg total RNA. 
both enzymes in all DNAs except in Hpall digestions of 1-83 (Fig 5, 
larre 2) and KB (Fig 5, larre 8) DNA. This suggests that GGCC sites 
have been methylated in the promoters of these lines. In addition, 
the 1-83 line contained a unique MspI band just below the 650-bp 
band (Fig 5, lalle 13, circled) . From this we conclude that a deletion 
may have occurred in one allele, affecting the size of the 650-bp 
fragment in 1-83. 
DISCUSSION 
SCC tumors and cultured lines vary in their expression of human 
TGase I protein and mRNA as measured by quantitative Western 
blotting and RT-PCR. We hypothesize that variat:ion may result 
from differences in the transcription ofTGase I, which might result 
from mutations or methylation in some cases. Secondly, whereas 
skin see tumors show reduced TGase I, the overlYing normal epi-
1 2 3 4 5 6 7891011 
A 
B 
-Figure 3. Northern blot analysis ofTGase I mRNA le-vels. Seven micro-
grams/lane total RNA blotted onto Zetabind membrane were hybridized to 
32P-CTP-oligolabcled TGase I eDNA. The filter was elCf'osed for 21 d with 
intensifying screens [17] (A). For comparison ofload, UV shadowing of the 
membrane was done (17) (B). mRNA ladder (BRL) was used to determine 
the size of the TGase I mRNA as 2.9 kb (arrow). Lalle I, A 431; lalle 2, KB; 
lalle 3, SRB-12; lalle 4, SRB-1; lalle 5, 14-83; lalle 6, 1-&3; laue 7, ME-180. 
Controls: Lane 8, human adult fibroblasts from skin ofbt-east reduction; lane 
9, human neonatal foreskin fibroblasts; lalle 10, humal1. foreskin keratino-
cytes at 70% confluency; and lalle 11, human foreskin ke:racinocytes at con-
fluency. 
lI) 
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Figure 4. Agarose gels stained with ethidium and visualized under UV 
light comain quantitative RT -PCR cDNA fragments from competitor ribo· 
probe (top balJd, upper arrow) and from endogenous mRNA (bottom baud, 
!owerarr?w). Levels ofTGase I mRNAderived from eDNA were quantitated 
111 keratl110cytes and SCC lines. Following eDNA synthesis, the products 
were split into eight tubes containing dilutions of competitor (pg amount 
shown above laues) and were subjected to 35 cycles ofPCR. Ten microliters 
of each reaction was loaded onto 4% N useive Agarose Gels and electrophor-
esed in Tris-EDT A-acetate buffer. Competitor alone is in lalle 2 and no 
competitor is in the last laue, as control. Extraneous bands are shown by ope" 
arrows. DNA V markers are in the first lalles (Boehringcr-Mannheim). Cul-
tured human foreskin keratinocytes (A) , SCC 1-83 (B), SCC 14-83 (C) , 
and A431 (D). 
dermis may express the enzyme abnormally. Tumors are well 
known to have heterogeneous behavior, response to vitamins or 
growth factors [24,50] , and expression of different antigens, tumor 
suppressor genes, and oncogenes [51,52]. This is the first demon-
stration that TGase I genetic mutations and variable n1.RNA levels 
are present in human squamous carcinomas. 
TGase I participates in squamous differentiation and has been 
suggested to be a useful marker for tumor progression [24]. Tenni-
nal differentiation of keratinizing epidermis requires formation of a 
cornified envelope catalyzed by epidermal (type 3) or keratinocyte 
(type 1) transglutaminase [4,13]. TGase I differs from the other 
transglutaminases by the addition of amino terminal amino acids 
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Figure 5. Southern blot of see genomic DNA (IOllg/lanc) cut with 
restriction enzymes and hybridized to a genomic promoter 2.3 HindIIl frag-
ment (A) or a 1.5-kb TGase I cDNA beginning at the active site (B) de-
scribed previously [17]. Lambda HilldIlI and Phi X174 fragments (BRL) 
were used as size markers. Filters were exposed for 5 d to Kodak XAR film 
with intensifying screens. A) Restriction fragments that hybridize to the 
2.3-TGase I promoter fragment are shown as follows: HilldIlI digestions 
(lanes 1,3,5,7,9,11), HpaII digestions (lall es 2,4,6,8,10,12) , and MspI diges-
tions (lall es 13-19). DNAs include see 1-83 (larles 1,2,13), see 14-83 
(la nes 3,4,14), A431 (Ialles 5,6,15), KB (Iatl es 7,8,16), ME-180 (Iall es 
9,10,17), SRB-I (lalle 18), and foreskin keratinocytes (farle 19). B) DNA 
restriction fragments that hybridize to the TGase I partial cDNA insert [17] 
were digested with MspI (lalles 1,2,3), HindIlI (lalles 4,6,8), and Hpall (Ialles 
5,7, 9). DNAs include 1-83 (falles 1,4,5), 14-83 (Ialles 2,6,7), and A431 
(la nes 3,8,9). 
important for myristylation and membrane anchorage [53,54]. The 
e=yme is localized in the cytoplasm as well as in the membrane, 
suggesting functions in addition to cornified envelope formation 
[20]. TGase I is also homologous to an erythrocyte structural pro-
tein (band 4.2 protein) and to other transglutaminases including 
Factor XIIIa, which stabilizes the fibrin clot [3,17,54]. Thus we 
speculate that TGase I may playa role in determining keratinocyte 
cell structure, membrane integrity, and possibly epidermal cohe-
siveness, which may be important in progression to malignancy and 
in metastasis. 
Some pulmonary carcinomas with squamous character lack 
TGase I expression uncoupled from another squamous differentia-
tion marker, involucrin [18]. Involucrin has been suggested to dis-
tinguish squamous malignancy from dysplasia [47] . In the fresh 
see tumors shown here, only the two most well-differentiated 
SCCs stained positively for TGase I, whereas the others were nega-
tive. Similarly, the well-differentiated SCC lines ME-180 and 14-
83 showed the greatest levels of protein expression, equal to or 
greater than those of cultured foreskin keratinocytes grown in low 
calcium. Because calcium is known to increase TGase I expression, 
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the level of protein expression ofkeratinocytes in low calcium may 
not be directly comparable to the levels in SCCs in high calcium in 
this particular study. The protein levels were in good correlation 
with the levels of mRNA detected (except for SRB-l) , suggesting 
that transcriptional control is important for determining the levels 
ofTGase 1. Transcriptional regulation has been suggested for TGase 
I expression in keratinocyte culture in response to calcium, retinoic 
acid, and phorbol esters [12,21,23 ,24,55-58]. It is possible that 
variation in cornification and expression ofTGase I in SCC lines or 
tumors [21] could reflect their degree of responsiveness to retinoids 
in serum [24,26]. 
Of interest, both BCCs and SCCs that lack TGase I appear to 
induce precocious expression of the enzyme in the overlying nor-
mal epidermis. This suggests that TGase I expression may be in-
duced in overlying tumors. TGase I immunoreactivity to B.Cl is 
seen just under the stratum corneum [5,59], although we have re-
ported previously, using ill situ hybridization [17], that TGase I 
mRNA is present in all epidermal layers and is markedly increased 
in psoriatic lesions. Both SCC and BCC tumors have been shown to 
express TGase I mRNA by il'l situ hybridization as well (Schroeder, 
Duvic [abstr.] Clin Res 529A, 1991). Others have reported a more 
restricted localization of the mRNA to the suprabasal layers [59]. 
Our study differs from other studies ofTGase I in squamous cell 
carcinomas [24,26,28] in that we measure both protein and mRNA 
in parallel and quantitatively with new highly sensitive methods 
[26,28,36]. Our data suggest that TGase I protein expression may be 
controlled by mRNA transcription levels in SCC lines, and is corre-
lated with state of differentiation. Quantitative RT-PCR was a 
more sensitive method for mRNA detection but showed good 
correlation with quantitative Northern blots. 
With the cloning of the cDNAs and genes for two distinct 
epidermally derived transglutaminases, TGase I (keratinocyte) 
[17,54,60-62] and TGase III (epidermal) [61], elucidation of mo-
lecular mechanisms for the heterogeneity of transglutaminase ex-
pression are possible. Loss of gene expression in tumors can result 
from the deletion of all or part of one or both alleles or frommeth-
ylation of key promoter regions controlling transcription. The 
TGase I gene was detected in all SCC DNAs studied but abnormal 
genomic fragment sites were noted in two lines that produced very 
low levels ofTGase I mRNA and no detectable TGase protein. 
The 1-83 lme had abnormal RT-PCR fragments and unique ge-
nomic restriction fragments in both the promoter and gene region, 
suggestmg that at least one of the alleles for this gene has structural 
mutations that affect multiple enzyme sites. Although restriction 
enzyme-length polymorph isms or partial digestions cannot be ex-
cluded! the presence of multiple restriction fragment changes is 
more likely due to a rearrangement, insertion, or deletion. 
Tumor lines in culture for many years may lose chromosomes or 
accumulate genetic mutations, so the significance of these findings 
for the development or progression of SCC is not yet known. The 
SCC 14-83, SRB-1, and SRB-12 lines have been in culture as long 
as 1-83, yet do not have detectable changes in their TGase I genes. 
No cytogenetic changes in chromosome 14, which contains the 
TGase I gene [17,63] have been found in the 1-83 line [29]' Analysis 
of DNA from fresh tumors would be helpful in determining the 
Importance of these observations. 
The methylation pattern of the promoter of the 1-83 and KB 
lines appears to be altered relative to other SCC and normal cell 
lines, as studied by methylation-sensitive enzymes. One allele of 
1-83 may also contain a deletion that affects a 650-bp MspI frag-
ment. Thus, the 1-83 line may have multiple changes including 
methylation and structural genomic mutations, resulting in lowered 
expression and truncated RT-PCR products. 
The variation in the expression of TGase I enzyme appears to 
correlate with the level of squamous differentiation, resulting per-
haps from several mechanisms affecting RNA transcription. Two of 
these may include methylation or mutations in the DNA promoter 
or gene structure. This is the first evidence to suggest that mutations 
within the TGase I gene and promoter are associated with human 
squamous cell carcinoma. The full function of TGase I is as yet 
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unknown but warrants further investigation with respect to squa-
mous differentiation and development of malignancy. 
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